Contrast Media Injectors Market - Global Size, Share, Trends, Growth and Forecast Year ( 2022 – 2032 )
Contrast Media Injectors Market Dynamics
Contrast Media Injectors Market by Product (Injector Systems, Consumables), Type (Single Head Injectors, Dual-Head Injectors, Syringeless Injectors), C Application (Radiology, Interventional Cardiology, Interventional Radiology), End-use Industry (Hospitals, Diagnostics Centers, Ambulatory Surgery Centers), and Geographic Regions (North America, Europe, Asia Pacific, Latin America, Middle East and Africa): Industry Trends and Global Forecasts, 2023-2032
Market Size and Overview :
Based on KD Market Insights' data, the contrast media injectors market is expected to demonstrate steady growth from 2023 to 2032, with a compound annual growth rate (CAGR) of 7.4%. The market value reached USD 2.4 billion by 2032. This growth is likely to be driven by increasing demand for minimally invasive surgeries and technological advancements. The minimally invasive surgeries increase the healthcare expenditure that gives rise to adopting contrast media injectors as it is an expensive procedure.
Contrast Media Injectors Market Report Scope
USD 1.2 billion
USD 2.4 billion
7.4% from 2023 to 2032
•High cost of contrast media injectors
•Lack of trained professionals
•Increasing prevalence of cancer
•New technologically improved solutions
•Rise in healthcare expenditure
- Injector Systems
- CT Injector Systems
- MRI injector systems
- Cardiovascular/angiography injector systems
- Single Head Injectors
- Dual-Head Injectors
- Syringeless Injectors
- Interventional Cardiology
- Interventional Radiology
- Diagnostics Centers
- Ambulatory Surgery Centers
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
CT Injector Systems: CT injector systems dominated the contrast media injectors market with a share of 53.7% in 2022. This is attributable to the rising widespread application of these systems in cancer surgery, neurosurgery, cardiovascular surgery, and spinal procedures.
Hospitals: the hospital segment dominates the market. This is because there are increasing admissions of patients suffering from neurological disorders, cardiovascular diseases, and cancer. Hospitals have wide applications uses of contrast media injectors in radiology, interventional radiology, and interventional cardiology and so, they are the primary users.
Regional Analysis :
The regional analysis of the contrast media injectors market reveals diverse trends and dynamics across different parts of the world. The North American region dominated the market share in 2022. This is because of the presence of well-established healthcare facilities and the easy availability of advanced technologies as well as the high demand for diagnostic procedures in this region. The United States and Canada are the significant markets of the region.
Moving to the Asia-pacific region, it is expected to grow during the forecast period. India, China, and Japan are the major markets in this region. The market is driven by rapidly developing economies, growing awareness about healthcare, and an aging population. There is a high demand for advanced surgical treatment solutions due to various chronic diseases like neurological disorders. This can boost the growth of advanced contrast media injectors. There is an increasing focus on the development of healthcare infrastructure in Asia-Pacific and African economies as they are considered developing economies of the world.
Growth Drivers :
The market is driven by rapid technological advancements, a rise in healthcare expenditure, along with improvement in the quality of patient care. Due to the rise in healthcare expenditure, hospitals are encouraged to introduce invasive surgeries that use contrast media injectors and give rise to the market. As more and more patients with cancer are increasing, there is a need for improved quality of diagnostic imaging and patient safety, which is provided by the contrast media when it is injected at the time of diagnostics. Thus, the need for advanced diagnostic imaging procedures directly stimulates the growth of contrast media injectors in the market.
An LCD screen is enabled with the contrast media injector to monitor the patient status and maintain the flow. New software is being introduced by the market players to generate real-time data that can provide easy access to information. This will reduce error rates, time, and efforts of the hospitals.
The cost of contrast media injectors is high. The cost can vary if the hospital prefers to use other types of injectors. Considering the hygiene and safety issues, the same syringe or tube cannot be used again, which increases the cost of consumables. This is a challenge for the end-user in adopting contrast media injectors due to the high cost. Besides this, highly skilled working professionals are required to handle the procedures. This may also cause hindrance to the contrast media injectors market.
Key Companies (200 words):
- Bayer HealthCare LLC
- Bracco Group
- GE Healthcare
- Ulrich Medical
- Guerbet Group
- Medtron AG
- Nemoto Kyorindo Co., Ltd.
- Sino Medical-Device Technology Co., Ltd.
- APOLLO RT Co. Ltd.
- Shenzhen Anke High-tech Co. Ltd
- Hong Kong Medi Co Limited
- Other Players
The report presents coverage of companies in the Contrast Media Injectors Market, such as Bayer Ag, Bracco Imaging S.p.A., Ulrich medical, and others.
In December 2022, Ulrich medical and GE Healthcare announced an agreement to market a branded multi-dose contrast media injector in the U.S.
In November 2022, GE Healthcare announced an investment of USD 80 million to increase contrast media production capacity.